IGG4-RELATED DISEASE
Clinical trials for IGG4-RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4-RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4-RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested to shrink swollen glands in rare disease
Disease control Recruiting nowThis study is testing if a drug called efgartigimod can reduce swelling in the tear glands, salivary glands, or pancreas of adults with IgG4-related disease. Participants will receive weekly injections for up to 12 weeks and have regular checkups and scans to see if the treatment…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Experimental cell therapy aims to tame rebellious immune system in chronic disease
Disease control Recruiting nowThis study is testing a new cell therapy for adults with IgG4-related disease, a chronic condition where the immune system attacks the body's own tissues. The therapy involves collecting a patient's own immune cells, modifying them in a lab to better target the disease, and then …
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New drug combo trial aims to tame mysterious autoimmune disease
Disease control Recruiting nowThis study is testing if adding a medication called lenalidomide to the standard steroid treatment works better for people with active IgG4-Related Disease (IgG4-RD). It will involve about 200 adults to see if the combination lowers the chance of the disease flaring up again over…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Donor cells tested to fight mysterious autoimmune disease
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called ACE1831 for people with active IgG4-Related Disease (IgG4-RD), a condition where the immune system attacks the body's own tissues. The therapy uses immune cells (gamma delta T cells) from healthy donors. Researchers will…
Matched conditions: IGG4-RELATED DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Acepodia Biotech, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC